Registration of securities issued in business combination transactions

Share-Based Compensation - Schedule of Fair Value Assumptions for Options (Details) (Mymd Pharmaceuticals Inc.)

v3.20.4
Share-Based Compensation - Schedule of Fair Value Assumptions for Options (Details) (Mymd Pharmaceuticals Inc.) - $ / shares
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Nov. 11, 2020
Minimum [Member]      
Common stock grant date fair value     $ 5.00
Mymd Pharmaceuticals Inc. [Member]      
Common stock grant date fair value $ 1.00 $ 1.00  
Expected dividend yield 0.00% 0.00%  
Expected term 5 years 5 years  
Mymd Pharmaceuticals Inc. [Member] | Minimum [Member]      
Risk-free interest rate 0.27% 1.37%  
Expected stock volatility 73.00% 70.90%  
Mymd Pharmaceuticals Inc. [Member] | Maximum [Member]      
Risk-free interest rate 1.43% 2.42%  
Expected stock volatility 75.80% 72.40%